InVivo Therapeutics Holdings CEO Richard Toselli's 2020 pay falls 34% to $832K
InVivo Therapeutics Holdings reports 2020 executive compensation
By ExecPay News
Published: May 18, 2021
InVivo Therapeutics Holdings reported fiscal year 2020 executive compensation information on May 18, 2021.
In 2020, two executives at InVivo Therapeutics Holdings received on average a compensation package of $695K, a 28% decrease compared to previous year.
Average pay of disclosed executives at InVivo Therapeutics Holdings
Richard Toselli, Chief Executive Officer, received $832K in total, which decreased by 34% compared to 2019. 60% of Toselli's compensation, or $499K, was in salary. Toselli also received $316K in bonus and $17K in other compensation.
Richard Christopher, Chief Financial Officer, received a compensation package of $558K, which decreased by 18% compared to previous year. 61% of the compensation package, or $343K, was in salary.
Related executives
You may also like
Source: SEC filing on May 18, 2021.